Wednesday, 16 May 2018

Press Release: BioLargo Achieves Record Product Sales and Revenues in Q1 2018















 Westminster, CA – May 16, 2018 – BioLargo, Inc. (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, announced that on May 14, 2018, it had filed its 10-Q quarterly report. Highlights from the quarterly report, found on the SEC’s website here, include:

  • Revenue from product sales for the three months ended March 31, 2018 increased by over 400% compared with the three months ended March 31, 2017, to approximately $225,000;
  • Revenue from product sales continues to increase after the end of the 1st quarter, reaching nearly $200,000 midway into the 2nd quarter; and
  • Average monthly revenue has increased from approximately $25,000 the first half of 2017, to almost $60,000 the second half of 2017, to approximately $95,000 per month thus far in 2018.

The company’s commercial prospects are further discussed in the Form 10-Q, as summarized here:

Odor-No-More:

  • A significant increase in sales to the U.S. Military of our Specimen Transport Solidifiers;
  • Recent approval as supplier for 100% of the regional locations of one of our large national waste management accounts;
  • In excess of $300,000 of bids submitted for design/construct/install of service equipment and systems to expand the use of CupriDyne Clean in client operations; and
  • Hiring of additional sales and account management staff to capitalize on momentum.

BioLargo Engineering, Science & Technologies (BLEST):

  • BLEST has been retained as “Owner’s Engineer” for a proposed $687M integrated biofuels production project on the east coast;
  • BLEST has more than 40 client proposals outstanding, for projects such as Legionella mitigation, VOC and oil & gas by-product control, and wastewater management, most significantly as a preferred supplier to a top oil & gas company to solve produced water clean up challenges at one of their facilities (if awarded, the contract is estimated to be worth $1.3M in revenue);

Clyra Medical

  • While we face delay in our first application for pre-market clearance filed with the FDA under Section 510(k), we have concluded design on a second product and are finalizing its 510(k) application;
  • While we remain confident that we will ultimately receive premarket clearance for our products, we can make no assurance or prediction as to success of Clyra’s efforts, and must wait patiently for the process with the FDA to conclude.

Advanced Oxidation System (AOS):

  • $235,000 Canadian grant awarded from the Canadian Government to fund the first on-site AOS pilot project, in the poultry industry, planned for 2018, the purpose of which is to lay the foundation for commercialization of the AOS; and
  • The company has also submitted and are currently submitting applications for a series of substantial government grants (totaling more than $4M USD) to focus on specific targets in industry, like wastewater, food processing and oil and gas applications.
Dennis P. Calvert, President of BioLargo, commented, “We are highly focused on executing our plan to grow sales and infrastructure for Odor-No-More, excited to see our engineering division bidding on significant projects, remain patient with the FDA at Clyra, and are looking forward to our pilot project for the AOS in Canada.

BioLargo proudly and regularly publishes information about its employees, products and activities through social media, including:

You can follow our twitter feeds here:
  • @BioLargo
  • @BioLargoWater
  • @OdorNoMore
  • @CupriDyneClean
About BioLargo, Inc.

BioLargo, Inc. is an innovative technology incubator and environmental engineering company driven by a mission to “make life better” by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We incubate disruptive technologies by providing the capital, support, and expertise to expedite them from “cradle” to “maturity” (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System “AOS”, a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.



Source: BioLargo, Inc.

Thursday, 10 May 2018

Dennis Calvert SNNLive Interview Video

You may have read that BioLargo President and CEO Dennis Calvert presented at the 2018 Planet MicroCap conference late last month. At the conference, Dennis was interviewed by SNNLive's Shelly Kraft about BioLargo's current exciting growth opportunities.

You can watch the short and sweet interview here below!


Wednesday, 9 May 2018

Press Release: BioLargo reduces balance sheet liabilities by more than $5,400,000


WESTMINSTER, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- BioLargo, Inc. (OTCQB:BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, announced that on May 7, 2018, it had reduced the liabilities on its balance sheet by $4,133,378, through the conversion of promissory notes into 15,747,482 shares of common stock. The notes converted had maturity dates ranging from June 1, 2018, through June 20, 2020, and had been issued to investors in the Company’s prior “unit” offerings. BioLargo also reported that it will convert an additional $1,314,380 of debt to equity on June 1, 2018, resulting in the issuance of 3,211,004 shares of common stock (plus shares for accrued interest) for a total reduction of $5,447,758 of debt to equity.

As detailed in a Form 8-K filed with the SEC today, the Company offered to investors additional shares as an incentive to convert their note prior to the maturity date. Holders of notes converting at $0.25 and $0.30 per share were offered shares equal to the amount of interest due on the note through maturity, paid at $0.25 a share, plus 50%. Holders of notes with conversion prices of $0.35, $0.55, and $0.57 were offered the ability to reduce the conversion price of their note to $0.30 by paying an amount equal to 6%, 20% and 20%, respectively. The Company announced it had received $261,781 in funds related to the reduction of conversion prices.

BioLargo President and CEO Dennis P. Calvert commented, “We are focused on shoring up our balance sheet and increasing our revenues. This debt reduction program provides immediate value to our investors and our company as we gear up for expansion.”

About BioLargo, Inc.
BioLargo, Inc. is an innovative technology incubator and environmental engineering company driven by a mission to “make life better” by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We incubate disruptive technologies by providing the capital, support, and expertise to expedite them from “cradle” to “maturity” (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System “AOS”, a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Tuesday, 1 May 2018

BioLargo Spotlight: BioLargo to Present CupriDyne Clean at China InnoSTARS Preliminary Competition in Houston


BioLargo’s subsidiary Odor-No-More has been invited to present at the China InnoSTARS Competition in Houston, TX, on May 14-15. China InnoSTARS is a prestigious platform for US-based technology companies to connect with strategic partners and investors in China. Winners of the preliminary competition will be invited for an all-expenses paid trip to China to present to hundreds of investors, fund managers, and potential clients and partners in Chinese innovation hub cities for the semi-final and grand finale competitions. The program is sponsored by the US China Innovation Alliance and the Ministry of Science and Technology of the government of China.

From: http://uschinainnovation.org/innostars2018/






The competition is judged by esteemed representatives from world-renowned organizations including Ecolab, AECOM, Danaher, Shell, and many more. Judges will decide which organizations move onto the semi-finals and grand-finale in China, where companies will compete for international renown and cash prizes. 

BioLargo will be presenting on Odor-No-More’s CupriDyneClean Industrial Odor and VOC Eliminator, which is currently enjoying accelerating market adoption in the United States’ solid waste management industry and wastewater treatment industries. There exists a large and under-served market for effective, cost-efficient, and eco-friendly control of unpleasant odors and volatile organic compounds (VOCs) in China. Odor-No-More’s CupriDyne Clean could benefit numerous cities in China while generating a significant new pool of revenue for the company.


What is a BioLargo Spotlight?
It’s an exciting time at BioLargo. We’re moving fast, and it can be difficult to keep our stockholders and the investing public informed of our progress. In light of this, we will be posting a series of short articles titled “BioLargo Spotlight”, highlighting certain business activities and other important information in between our required SEC filings. Of course, these do not replace our public filings, which contain more complete information than can be delivered in this forum, and thus we urge you to carefully read and rely on those filings for definitive information, and to review our risk factors and caution regarding forward-looking statements. We are optimistic about our business as we work hard to continue to grow and ultimately generate profits for our stockholders.  

widget